
Opinion|Videos|August 14, 2024
ESA-Ineligible LR MDS patient with Transfusion-Dependent Anemia
Author(s)Abdulraheem Yacoub, MD
Advertisement
Episodes in this series

Now Playing
Clinical Presentation:
74-year-old man diagnosed 6 months ago with LR-MDS with low-moderate anemia (Hb 11.4 g/dL)
Non-del(5q)
No family history of cancer or significant genotoxic agent exposure
Serum EPO – 550m U/L, Ring sideroblast (RS) negative
Hgb: 10.2 g/dL.
WBC and ANC: WNL
IPSS-R: Low
Received 2-3 units of blood every month for 4 months.
Treatment with ESAs is not an option due to his high serum EPO.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Sacituzumab Govitecan Misses PFS in First-Line HR+/HER2– Metastatic Breast Cancer
2
Medication Burden Linked With Acute Care Use in ARSI-Treated Prostate Cancer
3
Exploring the IO Interface: Bridging Knowledge Gaps in Immunotoxicity Management
4
First-in-Human Data Support Izalontamab in Advanced Epithelial Tumors
5







































